Cabaletta Bio (CABA) Depreciation and Depletion (2019 - 2025)
Cabaletta Bio's quarterly Depreciation and Depletion came in at $348000.0 in Q4 2025, down 25.64% year-on-year from $468000.0 in Q4 2024, and up 0.87% quarter-over-quarter from $345000.0 in Q3 2025.
Cabaletta Bio has reported Depreciation and Depletion for 7 years, with the latest figure at $348000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation and Depletion fell 25.64% year-over-year to $348000.0; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (down 3.8% YoY), and the FY2025 full-year result was $1.6 million, down 3.8% from the prior year.
- Depreciation and Depletion for Q4 2025 stood at $348000.0, up from $345000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $485000.0 in Q1 2025, with the low at $116000.0 in Q1 2021.
- Average Depreciation and Depletion over 5 years is $334700.0, with a median of $356500.0 recorded in 2022.
- Year-over-year, Depreciation and Depletion surged 145.56% in 2021 and retreated 25.64% in 2025.
- Tracing CABA's Depreciation and Depletion over 5 years: stood at $234000.0 in 2021, then surged by 52.99% to $358000.0 in 2022, then retreated by 6.15% to $336000.0 in 2023, then jumped by 39.29% to $468000.0 in 2024, then dropped by 25.64% to $348000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $348000.0 (Q4 2025), $345000.0 (Q3 2025), and $468000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 348,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 348,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Dec 31, 2024 | 468,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Sep 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 426,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Mar 31, 2024 | 393,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Dec 31, 2023 | 336,000.00 |
| Sep 30, 2023 | 355,000.00 |
| Sep 30, 2023 | 355,000.00 |
| Jun 30, 2023 | 370,000.00 |
| Jun 30, 2023 | 370,000.00 |
| Mar 31, 2023 | 365,000.00 |
| Mar 31, 2023 | 365,000.00 |
| Dec 31, 2022 | 358,000.00 |
| Dec 31, 2022 | 358,000.00 |
| Sep 30, 2022 | 363,000.00 |
| Sep 30, 2022 | 363,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Mar 31, 2022 | 219,000.00 |
| Mar 31, 2022 | 219,000.00 |
| Dec 31, 2021 | 234,000.00 |
| Dec 31, 2021 | 234,000.00 |
| Sep 30, 2021 | 221,000.00 |
| Sep 30, 2021 | 221,000.00 |
| Jun 30, 2021 | 162,000.00 |
| Jun 30, 2021 | 162,000.00 |
| Mar 31, 2021 | 116,000.00 |
| Mar 31, 2021 | 116,000.00 |
| Dec 31, 2020 | 110,000.00 |
| Dec 31, 2020 | 110,000.00 |
| Sep 30, 2020 | 90,000.00 |
| Sep 30, 2020 | 90,000.00 |
| Jun 30, 2020 | 78,000.00 |
| Jun 30, 2020 | 78,000.00 |
| Mar 31, 2020 | 76,000.00 |
| Mar 31, 2020 | 76,000.00 |
| Dec 31, 2019 | 51,000.00 |
| Dec 31, 2019 | 51,000.00 |
| Sep 30, 2019 | 32,000.00 |
| Sep 30, 2019 | 32,000.00 |